Effect of Human Platelet Lysate as Cultivation Nutrient Supplement on Human Natal Dental Pulp Stem Cell In Vitro Expansion.

culture medium nutrient supplement fetal bovine serum human natal stem cells human platelet lysate mesenchymal stem cells regenerative medicine stem cell cultivation

Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
08 08 2022
Historique:
received: 18 07 2022
revised: 04 08 2022
accepted: 06 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

Despite several scientific or ethical issues, fetal bovine serum (FBS) remains the standard nutrient supplement in the mesenchymal stem cell cultivation medium. Cell amplification plays an important role in human stem cell therapies. Increasing interest in this field has supported attempts to find suitable human alternatives to FBS for in vitro cell propagation. Human platelet lysate (hPL) has recently been determined as one of them. Our study aimed to evaluate the influence of 2% hPL in the growth medium for in vitro expansion of human natal dental pulp stem cells (hNDP-SCs). The effect was determined on proliferation rate, viability, phenotype profile, expression of several markers, relative telomere length change, and differentiation potential of four lineages of hNDP-SCs. As a control, hNDP-SCs were simultaneously cultivated in 2% FBS. hNDP-SCs cultivated in hPL showed a statistically significantly higher proliferation rate in initial passages. We did not observe a statistically significant effect on mesenchymal stem cell marker (CD29, CD44, CD73, CD90) or stromal-associated marker (CD13, CD166) expression. The cell viability, relative telomere length, or multipotency remained unaffected in hNDP-SCs cultivated in hPL-medium. In conclusion, hPL produced under controlled and standardized conditions is an efficient serum supplement for in vitro expansion of hNDP-SCs.

Identifiants

pubmed: 36008985
pii: biom12081091
doi: 10.3390/biom12081091
pmc: PMC9405745
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Biomolecules. 2021 Mar 20;11(3):
pubmed: 33804786
Biomaterials. 2012 Jul;33(20):5023-35
pubmed: 22516606
Braz Dent J. 2018 Sep-Oct;29(5):427-434
pubmed: 30517440
Cytotherapy. 2012 May;14(5):540-54
pubmed: 22296115
Cytotherapy. 2012 Nov;14(10):1159-63
pubmed: 23066784
Dev Genet. 1998;22(4):374-85
pubmed: 9664689
Regen Med. 2011 Jan;6(1):67-79
pubmed: 21175288
Cells Tissues Organs. 2020;209(4-6):257-265
pubmed: 33752213
Haematologica. 2007 Sep;92(9):1208-15
pubmed: 17666368
Biomed Res Int. 2020 May 09;2020:4671989
pubmed: 32461990
Cell Res. 2007 Jan;17(1):42-9
pubmed: 17211451
Cytotherapy. 2013 Dec;15(12):1469-83
pubmed: 23981539
Cells. 2020 Apr 09;9(4):
pubmed: 32283663
Transfusion. 2007 Aug;47(8):1436-46
pubmed: 17655588
J Transl Med. 2020 Sep 15;18(1):351
pubmed: 32933520
J Immunol Res. 2014;2014:987678
pubmed: 24741639
J Am Dent Assoc. 1984 Sep;109(3):441-3
pubmed: 6592231
Stem Cell Res Ther. 2021 Aug 30;12(1):488
pubmed: 34461987
Biomaterials. 2016 Jan;76:371-87
pubmed: 26561934
Stem Cells Int. 2014;2014:457059
pubmed: 25379041
Acta Histochem. 2019 May;121(4):491-499
pubmed: 31005288
Leukemia. 2006 May;20(5):894-6
pubmed: 16525488
Endocr Metab Immune Disord Drug Targets. 2019;19(8):1177-1191
pubmed: 30819088
Cell Transplant. 2011;20(11-12):1693-705
pubmed: 21396170
Cytotherapy. 2014 Feb;16(2):170-80
pubmed: 24438898
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jun;85(6):638-46
pubmed: 9638695
ISRN Pediatr. 2013 Aug 18;2013:956269
pubmed: 24024038
Arch Dis Child Fetal Neonatal Ed. 2002 Nov;87(3):F227
pubmed: 12391001
Transfus Med Hemother. 2013 Oct;40(5):326-35
pubmed: 24273486
Exp Hematol. 2004 Dec;32(12):1212-25
pubmed: 15588946
Stem Cells Int. 2018 Apr 15;2018:8973613
pubmed: 29760738
J Biomed Biotechnol. 2010;2010:673513
pubmed: 20976265
Stem Cells. 2007 Jan;25(1):197-202
pubmed: 17008421
Biochimie. 2008 Jan;90(1):33-40
pubmed: 18029083
J Natl Med Assoc. 2006 Feb;98(2):226-8
pubmed: 16708508
Am J Dis Child. 1986 Mar;140(3):249-51
pubmed: 3946356
J Cell Physiol. 1998 Feb;174(2):194-205
pubmed: 9428806
Blood Rev. 2009 Jul;23(4):177-89
pubmed: 19450911
Eur Surg Res. 2018;59(3-4):265-275
pubmed: 30244245
Stem Cells. 2009 Sep;27(9):2331-41
pubmed: 19544413
Folia Biol (Praha). 2019;65(3):124-133
pubmed: 31638559
Acta Medica (Hradec Kralove). 2014;57(3):119-26
pubmed: 25649367
Acta Medica (Hradec Kralove). 2004;47(4):229-33
pubmed: 15841901
ALTEX. 2018;35(1):99-118
pubmed: 28800376
Histochem Cell Biol. 2010 Jan;133(1):95-112
pubmed: 19816704
Cytotherapy. 2015 Dec;17(12):1793-806
pubmed: 26589754
Arch Oral Biol. 1999 Apr;44(4):361-71
pubmed: 10348363
J Int Acad Periodontol. 2003 Jul;5(3):63-70
pubmed: 12887144
J Cell Physiol. 2005 Nov;205(2):228-36
pubmed: 15887229
Stem Cells. 2020 Feb;38(2):261-275
pubmed: 31721342
Int J Hematol Oncol Stem Cell Res. 2016 Jul 1;10(3):161-71
pubmed: 27489592
Histol Histopathol. 2013 Sep;28(9):1109-16
pubmed: 23588700

Auteurs

Nela Pilbauerova (N)

Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.

Jan Schmidt (J)

Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.

Tereza Suchankova Kleplova (T)

Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.

Tomas Soukup (T)

Department of Histology and Embryology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic.

Jakub Suchanek (J)

Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH